Early childhood weight patterns linked to future obesity risk

Not all children grow the same way. A new study from the Environmental influences on Child Health Outcomes...

Adult-onset type 1 diabetes linked to higher cardiovascular and mortality risk

A new study in the European Heart Journal shows that people who develop type 1 diabetes in adulthood...

Sleep deprivation increases inflammation linked to heart disease risk

Even a few nights with insufficient sleep increases promote molecular mechanisms linked to a greater risk of heart...

Heart Disease in Women: Understanding Gender-Specific Cardiovascular Health

Cardiovascular disease remains the leading cause of death among women worldwide, yet for decades, our understanding of heart...

Residual inflammation can linger in psoriasis patients despite skin treatment

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics,...

Measles cases surge in the United States amid falling vaccination rates

The United States is in the midst of the second-highest year of measles cases since 2000, when the...

Intermittent fasting may dampen inflammatory responses in the gums

New research presented today at EuroPerio11, the world's leading congress in periodontology and implant dentistry by the European...

Gum disease bacterium linked to increased risk of atrial fibrillation

Tempted to skip the floss? Your heart might thank you if you don't. A new study from Hiroshima...

Blood and urine tests reveal how much ultra-processed food you really eat, study finds

Scientists have identified unique metabolic fingerprints in blood and urine that can objectively track ultra-processed food intake, paving...

Unlocking the secrets of human longevity and healthy aging

Human healthy aging and longevity are complex phenomena influenced by a dynamic interplay of genetic, epigenetic, metabolic, immune,...

Tirzepatide outperforms semaglutide in weight loss clinical trial

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy)...

Are one-year-olds in Australia eating right? New study reveals nutrient gaps

New research from the ORIGINS study shows that while toddlers in Australia meet many dietary targets, some, especially...

Maternal testosterone levels shape boys’ activity and girls’ strength by age 7

New research links maternal PCOS and testosterone to reduced weekend activity in boys and weaker grip strength in...

Cardiac MRI could help detect lamin heart disease

Magnetic resonance imaging (MRI) scans of the heart could help to detect a life-threatening heart disease and enable...

Early TAVR shows greatest stroke reduction in patients aged 65 to 70

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old...

Tirzepatide outperforms semaglutide for weight loss in people without diabetes

A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide, reshaping...

US hospitals see rising complications in patients with takotsubo cardiomyopathy

New research reveals takotsubo cardiomyopathy remains a major cause of in-hospital deaths and complications, with men facing more...

Controlling key health risk factors can eliminate early death risk from high blood pressure

A new study led by researchers at Tulane University suggests that people with high blood pressure can significantly...

Flavan-3-ols in tea and chocolate can lower blood pressure

We might have another reason to enjoy our daily cup of tea or small piece of dark chocolate,...

Chronic overwork may lead to changes in brain regions associated with emotion and cognition

Long working hours may alter the structure of the brain, particularly the areas associated with emotional regulation and...

Acetate and gut bacteria work together to reduce obesity in mice

Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have discovered a new way to reduce obesity. Their study shows that supplying the gut with extra acetate reduces fat and liver mass in both normal and obese mice, as long as bacteria of the Bacteroides species is also present in the gut. When both these conditions are met, gut bacteria can eliminate more sugars from the gut and promote the burning of fats for energy in the host. The findings were published in the scientific journal Cell Metabolism.

Affecting hundreds of millions of people around the world, obesity constitutes a global epidemic. It is linked to eating too much sugar and starchy foods and is known to increase the risk of heart disease, type-2 diabetes, and cancer. At the same time, studies show that eating fiber reduces the risk of the these very same diseases—even though it cannot be digested directly by mammals. When fiber reaches your gut—the large intestine to be precise—it is fermented by bacteria and the byproducts are released into the gut lumen, with some of them making it into the bloodstream.

The most common of these byproducts is acetate, which is known to have some beneficial effects on host metabolism. Although this makes dietary fiber a good "prebiotic", individual variation in the production of acetate and other useful byproducts limits its efficacy. To get around this problem, Ohno and his team previously developed a kind of acetate supplement by combining it with cellulose. AceCel ensures acetate reaches the distal large intestine where it can work its magic.

In the new study, the team investigated how AceCel affects mouse metabolism and the composition of gut bacteria. They found that when given AceCel, both normal and obese mice lost weight without losing muscle mass. This was not true for other short-chain fatty-acid byproducts, meaning that acetate itself is the key. Further tests were designed to figure out how this was happening.

They next discovered that compared with mice on a normal diet, when AceCel-fed mice were resting, they generated more energy from burning liver fat and less from burning carbohydrates. This is similar to what happens when fasting or on a low carb, keto diet, and promotes weight loss. Hypothesizing that the effects on the gut microbiome would also be similar, they analyzed the gut microbiota, finding that eating AceCel led mice to have more Bacteroides bacteria in their guts.

They then tested AceCel in mice that had controlled gut microbiota: either no bacteria at all, or one of several Bacteroides species. They found that AceCel had no effect on body, liver, or fat mass in the gut-bacteria free mice, while three Bacteroides species had similar positive effects on each. This means that the specific combination of acetate and Bacteroides bacteria in the intestines is necessary for the observed weight loss to occur.

Digging deeper, they found that this combination leads to more fermentation of carbohydrates in the gut, meaning that there is less sugar available for the host to process. By eliminating the sugars, fat-derived energy is promoted and less sugar is stored as glycogen in the liver, thus explaining how obesity is reduced.

Developing a treatment or prevention strategy for obesity is an urgent issue that must be solved quickly. We found that acetylated cellulose can prevent obesity by modulating the function of the gut microbiome.

Our next step is to confirm the safety and efficacy of using acetylated cellulose to treat obesity in humans. If so, it could become an important ingredient in functional foods that prevent obesity."

Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences 

Source:

RIKEN

Journal reference:

Takeuchi, T., et al. (2025). Acetylated cellulose suppresses body mass gain through gut commensals consuming host-accessible carbohydrates. Cell Metabolism. doi.org/10.1016/j.cmet.2025.04.013.


Source: http://www.news-medical.net/news/20250519/Acetate-and-gut-bacteria-work-together-to-reduce-obesity-in-mice.aspx

Inline Feedbacks
View all comments
guest